Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07162428

The Effect of Art Therapy on Disease Severity and Anxiety Levels in Inpatients at a Psychiatry Clinic

The aim of this study is to examine the effect of art therapy applied to inpatients in the psychiatry ward on disease severity and anxiety levels. Art therapy is considered a complementary intervention that can positively contribute to the psychiatric recovery process by facilitating the expression and regulation of an individual's emotional state.

This research will be conducted with a randomized controlled design and aims to demonstrate the effectiveness of art therapy practices within the clinical process through objective data. The originality of the study lies in the fact that art therapy will be implemented with individuals hospitalized in an acute psychiatric ward. In this respect, the study provides the opportunity to evaluate the applicability of art therapy even during crisis periods and carries the potential to make significant practice-oriented contributions to the field of mental health.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

About this study

Mental health is currently defined as a significant public health issue on a global scale. Mental disorders manifest across a wide spectrum, ranging from mild anxiety disorders to behavioral abnormalities. Psychiatric illnesses not only diminish individuals' quality of life but also impose substantial social and economic burdens on healthcare systems.

Alternative and complementary treatment methods are gaining increasing importance in alleviating this burden. In this context, art therapy has recently attracted attention as a supportive method in psychiatric treatments. The British Association of Art Therapists (BAAT) defines art therapy as "a form of psychotherapy in which art materials are used as the primary medium of expression and communication," whereas the American Art Therapy Association (AATA) defines it as "a mental health and human services profession that integrates creative processes, psychological theory, and human experience".

Art therapy represents a multidimensional approach that encompasses various practices such as drama therapy, dance-movement psychotherapy, body therapy, music therapy, painting, drawing, and crafts. This form of therapy aims to promote recovery not only at the mental level but also at the physical and emotional levels in the treatment of psychiatric disorders .

Research has shown that art therapy enhances individual expressive abilities, facilitates emotion regulation, and provides a personalized healing process. It has been demonstrated to yield effective results particularly in post-traumatic stress disorder (PTSD), personality disorders, and mood disorders. Furthermore, its effectiveness in reducing depression in elderly individuals has been supported by randomized controlled trials. Similarly, studies on reducing anxiety levels in children have also reported positive outcomes.

This study aims to investigate the effect of art therapy practices on disease severity and anxiety levels among inpatients in a psychiatric ward, using a randomized controlled trial design. The originality of this study lies in its implementation of art therapy with individuals hospitalized in an acute psychiatric ward. In this regard, examining the direct impact of art therapy within the clinical process has the potential to provide significant practical contributions for both practitioners and the healthcare system.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18 years or older.

Currently hospitalized in the psychiatry clinic and expected to remain hospitalized during the study period.

No medical condition such as intellectual disability or organic mental disorder that would interfere with the administration of scales and tests.

A PANSS score of ≤62 (since a score of 61 is considered the remission criterion in schizophrenia, patients scoring 62 or below will be included).

A score between 5-18 on the Young Mania Rating Scale.

Receiving treatment in the clinic for at least 3 days.

Providing verbal and/or written informed consent to participate in the study.

Exclusion criteria

Being in an acute psychotic episode or having severe psychotic symptoms (e.g., severe delusions, hallucinations) making the patient unsuitable for group participation.

Clinical conditions involving excessive agitation or homicidal risk that make group participation inappropriate.

Inability to actively participate in art therapy due to visual, hearing, or severe motor impairments.

Patients for whom discharge is planned during the clinical course (e.g., those scheduled for discharge in less than 3 days).

Diagnosis of an organic mental disorder (e.g., dementia, delirium).

Severe physical illness or motor impairment preventing participation in group activities

Treatment and study plan

Art Therapy

Behavioral

The art therapy sessions will be conducted by a certified art therapist who has completed a two-year training program, together with a psychiatric nurse who has completed a 4-hour training course on "Severe Personality Disorders and Therapeutic Interventions - Art Therapy." A clinical nurse and a psychiatry resident will also participate as observers. The therapist will deliver the intervention through semi-structured sessions, following a predefined content and method. These sessions are referred to as Semi-Structured Art Therapy Sessions.

Primary outcomes

  1. Young Mania Rating Scale (YMRS)

    Time frame: Before and after each therapy session (daily assessments during the 5-day intervention week for each group). Each group receives one week of therapy; in total, three groups will complete the intervention over three consecutive weeks.

    The YMRS is an 11-item scale developed by Young et al. to assess the severity of manic episodes. Seven items are rated on a 5-point Likert scale and four items on a 9-point Likert scale, with a total score range of 0 to 44. The Turkish version has been validated for reliability and validity. The total score can range from 0 to 60, with higher scores indicating more severe manic symptoms.

  2. State-Trait Anxiety Inventory (STAI - Form I and II)

    Time frame: Before and after each session across the 5-day intervention week for each group (three groups in total, over three weeks).

    Self-report measure assessing state and trait anxiety, consisting of 20 items each, rated on a 4-point Likert scale.

  3. Positive and Negative Syndrome Scale (PANSS)

    Time frame: Before and after each session across the 5-day intervention week for each group (three groups in total, over three weeks).

    The PANSS is a 30-item scale developed by Kay et al. to assess positive symptoms, negative symptoms, and general psychopathology in schizophrenia. Scores are rated across three subscales. The Turkish version has been validated by Kostakoğlu et al. In this scale (PANSS: Positive and Negative Syndrome Scale), as the score increases, symptoms/psychopathology become more severe. In other words, the higher the score, the greater the severity of symptoms and the greater the impairment in the patient's daily functioning.

Study contacts

Contact information is provided by the study sponsor or research team.

Tuğba ŞAHİN TOKATLIOĞLU, Dr.

CONTACT

[email protected]

+90539 474 87 07

Sponsors and collaborators

Lead sponsor

Koç University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 9, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.